Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 55, Issue 7-8, 2010, Pages 285-295

  Harvey, Richard A ^{a,b,c,d,e,f,g}   Mitchell, Hugh D C ^{a,b,c,d,e,f,g}   Stenman, Ulf Håkan ^{a,b,c,d,e,f,g}   Blankenstein, Rien ^{a,b,c,d,e,f,g}   Nustad, Kjell ^{a,b,c,d,e,f,g}   Stieber, Petra ^{a,b,c,d,e,f,g}   Stewart, Wilson ^{a,b,c,d,e,f,g}   Savage, Philip M ^{a,b,c,d,e,f,g}   Seckl, Michael J ^{a,b,c,d,e,f,g}   Braunstein, Glenn D ^{a,b,c,d,e,f,g}  

^a Charing Cross Gestational Trophoblastic Disease Centre   (United Kingdom)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f NINEWELLS HOSPITAL   (United Kingdom)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Germ cell tumor; Gestational trophoblastic disease; Human chorionic gonadotropin; International reference reagent

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ANALYTIC METHOD; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERM CELL TUMOR; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; OVARY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TESTIS; TROPHOBLASTIC TUMOR; WORLD HEALTH ORGANIZATION; ADULT; AGED; BLOOD; CHORIOCARCINOMA; COMPARATIVE STUDY; EVALUATION; HYDATIDIFORM MOLE; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PREGNANCY; TESTIS TUMOR; UTERUS CANCER;

ADULT; AGED; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYDATIDIFORM MOLE, INVASIVE; IMMUNOASSAY; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PREGNANCY; TESTICULAR NEOPLASMS; UTERINE NEOPLASMS;

EID: 77957258102     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stenman U-H, Alfthan H, Hotakainen K: Human chorionic gonadotropin in cancer. Clin Biochem 2004;37:549-561
2. Stenman U-H, Tiitinen A, Alfthan H, et al: The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 2006;12:769-784
3. Muller CY, Cole LA: The quagmire of hCG and hCG testing in gynaecologic oncology. Gynecol Oncol 2009;112:663-672
4. Berger P, Kranewitter W, Madersbacher S, et al: Eutopic production of human chorionic gonadotropin beta (hCG beta) and luteinizing hormone beta (hLH beta) in the human testis. FEBS Lett 1994;343:229-233
5. Dirnhofer S, Hermann M, Hittmair A, et al: Expression of the human chorionic gonadotropin-beta gene cluster in human pituitaries and alternate use of exon 1. J Clin Endocr Metab 1996;81:4212-4217
6. Carlsen RB, Bahl OP, Swaminathan N: Human chorionic gonadotropin: Linear amino acid sequence of the beta subunit. J Biol Chem 1973;10:6810-6827
7. Mcfarland KC, Sprengel R, Phillips HS, et al: Lutropinchoriogonadotropin receptor: An unusual member of the G protein- coupled receptor family. Science 1989;245:494-499
8. Sturgeon CM, Berger P, Bidart J-M, et al: Differences in recognition of the 1st WHO International Reference Reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem 2009;55:1484-1491
9. Whittington J, Fantz CR, Gronowski AM, et al: The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents. Clin Chim Acta 2010;411:81-85
10. Alfthan H, Haglund C, Dabek J, et al: Concentrations of human choriogonadotropin, its ß- subunit and the core fragment of the ß-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38:1981-1987
11. Kovalevskaya G, Birken S, Kakuma T, et al: Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol 1999;161:99-106
12. Cole LA, Khanlian SA, Sutton JM, et al: Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem 2003;36:647-655
13. Valmu l, Alfthan H, Hotakainen K, et al: Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatographyelectrospray mass spectrometry. Glycobiology 2006;16:1207-1218
14. Lottersberger C, Hoermann R, Mann K, et al: Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: Biological and diagnostic relevance. Horm Res 2003;59: 125-134
15. Marcillac I, Troalen F, Bidart J-M, et al: Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-3907
16. Berger P, Sturgeon C, Bidart JM, et al: The ISOBM TD-7 Workshop on hCG and related molecules: Towards useroriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol 2002;23:1-38
17. Birken S, Berger P, Bidart JM, et al: Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003;49:144-154
18. Bristow A, Berger P, Bidart J-M, et al: Establishment, value assignment, and characterization of new WHO Reference Reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005;51:177-182
19. Bock JL: HCG assays: A plea for uniformity. Am J Clin Pathol 1990;93:432-433
20. Cole LA, Sutton JM, Higgins TN, et al: Between-method variation in human chorionic gonadotropin test results. Clin Chem 2004;50:874-882
21. Cole LA, Kardana A: Discordant results in human chorionic gonadotropin assays. Clin Chem 1992;38:263-270
22. Cole LA, Shahabi S, Butler SA, et al: Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001;47:308-315
23. Mitchell H, Seckl MJ: Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG. Mol Cell Endocrinol 2007;260:310-313
24. Cole LA: Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997;43:2233-2243
25. Vaitukaitis JL, Braunstein GD, Ross GT: A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972;113:751-758
26. Lempiainen A, Stenman U-H, Blomqvist C, et al: Free betasubunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer. Clin Chem 2008;54:1840-1843
27. Stenman U-H: Standardization of assays for human chorionic gonadotropin. Clin Chem 2004;50:798-800
28. Birken S, Kovalevskaya G, O'Connor J: Immunochemical measurement of early pregnancy isoforms of hCG: Potential applications to fertility research, prenatal diagnosis, and cancer. Arch Med Res 2001;32:635-643
29. Cole LA, Birken S, Sutphen S, et al: Absence of the COOHterminal peptide on ectopic human chorionic gonadotropin beta-subunit (hCG beta). Endocrinology 1982;110:2198-2200
30. Ekins R: Immunoassay standardisation. Scand J Clin Lab Invest Suppl 1991;205:33-46
31. Stenman UH: Immunoassay standardization: Is it possible, who is responsible, who is capable? Clin Chem 2001;47:815-820